Skip to main content

Table 6 Multivariate analysis by the Cox proportional hazard regression model for OS in younger GBM patients (age < 60 years) from tumor banks

From: Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patients

Variable HR (95% CI) P
Gender   
 Male vs female NA 0.791
LANCL2 gene status   
 Amplification vs no alteration 2.199 (1.142–4.236) 0.018
EGFR gene status   
 Amplification vs no alteration NA 0.805
LANCL2 and EGFR genes status   
 Co-amplification vs no alteration NA 0.845
  1. HR hazard ratio, CI confidence interval, NA not applicable